Skip to main content
. 2013 Apr 10;15(1):30. doi: 10.1186/1532-429X-15-30

Table 1.

Model input parameters

Parameter Value Range Ref.
SnC
Sensitivity of CMR
0.82
0.77-0.86
[17]
SpC
Specificity of CMR
0.86
0.82-0.89
[17]
SnS
Sensitivity of SPECT
0.67
0.60-0.72
[17]
SpS
Specificity of SPECT
0.83
0.79-0.86
[17]
SnA
Sensitivity of angiography
1.00
N/A
[19-21]
SpA
Specificity of angiography
1.00
N/A
[19-21]
RC
Complication rate with CMR
0.0005
0.0001-0.001
[23]
RS
Complication rate with SPECT
0.0005
0.0001-0.001
[20]
RA
Complication rate with angiography
0.005
0.001-0.01
[28]
RF
Complication rate for patients with CAD and false-negative test results*
0.25
0.15-0.30
[20,21]
MC
Mortality rate due to CMR
0.00005
0.00001-0.0001
[20,24]
MS
Mortality rate due to SPECT
0.00005
0.00001-0.0001
[20,24]
MA
Mortality rate due to angiography
0.00075
0.0001-0.0015
[28]
MF
Mortality rate for patients with CAD and false-negative test results*
0.20
0.15-0.25
[19,20]
NDxC
Rate of non-diagnostic CMR
0.05
0.01-0.1
[17,25]
NDxS
Rate of non-diagnostic SPECT
0.05
0.01-0.1
[17,25]
NDxA
Rate of non-diagnostic angiography
0.00
N/A
[19-21]
CC
Cost of CMR [in €]
703
527-879
[31,34]
CS
Cost of SPECT [in €]
504
378-630
[30,33]
CA
Cost of angiography [in €]
2,926
2,195-3,658
[29,35]
C
Cost of a complication# [in €]
14,478
10,859-18,098
[21,36]
NC
No. of patients having CMR
1.0
N/A
[21]
NS
No. of patients having SPECT
1.0
N/A
[21]
NA
No. of patients having angiography
varies
Equation 1a
[19-21]
NFC
No. of false-negative CMR
varies
Equation 1a
[19-21]
NFS
No. of false-negative SPECT
varies
Equation 1a
[19-21]
P
Prevalence of CAD
varies
0.1-1.0
[19-21]
ΔQALY’
QALY extended by CAD therapy*
3.0
2.0-4.0
[20]
ΔQALY Net QALY gained varies Equations 1c,2c [20]

*Over a 10-year follow-up period.

#Assumed to be myocardial infarction (or cerebral, for invasive angiography).

Angiography refers to invasive coronary angiography. Details of the parameters are given in the text.

CAD: coronary artery disease; CMR: cardiovascular magnetic resonance; N/A: not applicable; QALY: quality-adjusted life-year; SPECT: single-photon emission computed tomography.